{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(6)"],"submitter":["Jiang T"],"journal":["Translational lung cancer research"],"pagination":["2514-2517"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7815344"],"repository":["biostudies-literature"],"pubmed_title":["Osimertinib in combination with bevacizumab in <i>EGFR</i>-Mutated NSCLC with leptomeningeal metastases."],"pmcid":["PMC7815344"],"pubmed_authors":["Hu J","Zhou C","Ding N","Jiang T","Chen X","Xu X","Hu Q"],"additional_accession":[]},"is_claimable":false,"name":"Osimertinib in combination with bevacizumab in <i>EGFR</i>-Mutated NSCLC with leptomeningeal metastases.","description":null,"dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2025-04-05T14:48:03.754Z","creation":"2025-02-19T01:41:15.694Z"},"accession":"S-EPMC7815344","cross_references":{"pubmed":["33489813"],"doi":["10.21037/tlcr-20-984"]}}